๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Œ๐ž๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐๐ž๐ซ๐ฎ ๐ˆ๐ง-๐•๐ข๐ญ๐ซ๐จ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐“๐ก๐ž ๐๐ž๐ซ๐ฎ ๐ˆ๐ง-๐•๐ข๐ญ๐ซ๐จ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions.

๐Š๐ž๐ฒ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ :

๐‘๐ข๐ฌ๐ข๐ง๐  ๐๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐‚๐ก๐ซ๐จ๐ง๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies.

๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth.

๐ˆ๐ฆ๐ฉ๐จ๐ซ๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%.

https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Œ๐ž๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐๐ž๐ซ๐ฎ ๐ˆ๐ง-๐•๐ข๐ญ๐ซ๐จ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ก๐ž ๐๐ž๐ซ๐ฎ ๐ˆ๐ง-๐•๐ข๐ญ๐ซ๐จ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions. ๐Š๐ž๐ฒ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ : ๐‘๐ข๐ฌ๐ข๐ง๐  ๐๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐‚๐ก๐ซ๐จ๐ง๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies. ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth. ๐ˆ๐ฆ๐ฉ๐จ๐ซ๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%. https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
WWW.NEXTMSC.COM
Peru In-Vitro Diagnostics Market Size and Share|2024??? 2030
The Peru In-Vitro Diagnostics Market valued USD 135.0 Mn in 2023, and it is projected to hit USD 163.3 Mn by 2030
0 Kommentare 0 Geteilt 33 Ansichten 0 Bewertungen
Gesponsert